These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
584 related articles for article (PubMed ID: 15069204)
1. Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. Iijima K; Liu HP; Chiang AS; Hearn SA; Konsolaki M; Zhong Y Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6623-8. PubMed ID: 15069204 [TBL] [Abstract][Full Text] [Related]
2. Brain aging and Aβ₁₋₄₂ neurotoxicity converge via deterioration in autophagy-lysosomal system: a conditional Drosophila model linking Alzheimer's neurodegeneration with aging. Ling D; Salvaterra PM Acta Neuropathol; 2011 Feb; 121(2):183-91. PubMed ID: 21076961 [TBL] [Abstract][Full Text] [Related]
4. A model for studying Alzheimer's Abeta42-induced toxicity in Drosophila melanogaster. Finelli A; Kelkar A; Song HJ; Yang H; Konsolaki M Mol Cell Neurosci; 2004 Jul; 26(3):365-75. PubMed ID: 15234342 [TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils. Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812 [TBL] [Abstract][Full Text] [Related]
6. Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. Crowther DC; Kinghorn KJ; Miranda E; Page R; Curry JA; Duthie FA; Gubb DC; Lomas DA Neuroscience; 2005; 132(1):123-35. PubMed ID: 15780472 [TBL] [Abstract][Full Text] [Related]
7. Enhanced neurite outgrowth and branching precede increased amyloid-β-induced neuronal apoptosis in a novel Alzheimer's disease model. Saad Y; Segal D; Ayali A J Alzheimers Dis; 2015; 43(3):993-1006. PubMed ID: 25125474 [TBL] [Abstract][Full Text] [Related]
8. SH2B1 is Involved in the Accumulation of Amyloid-β42 in Alzheimer's Disease. Shen Y; Xia Y; Meng S; Lim NK; Wang W; Huang F J Alzheimers Dis; 2017; 55(2):835-847. PubMed ID: 27802221 [TBL] [Abstract][Full Text] [Related]
9. Glial Draper Rescues Aβ Toxicity in a Ray A; Speese SD; Logan MA J Neurosci; 2017 Dec; 37(49):11881-11893. PubMed ID: 29109235 [TBL] [Abstract][Full Text] [Related]
10. Exogenous expression of Drp1 plays neuroprotective roles in the Alzheimer's disease in the Aβ42 transgenic Drosophila model. Lv F; Yang X; Cui C; Su C PLoS One; 2017; 12(5):e0176183. PubMed ID: 28531191 [TBL] [Abstract][Full Text] [Related]
12. Wild-type, Flemish, and Dutch amyloid-β exhibit different cytotoxicities depending on Aβ40 to Aβ42 interaction time and concentration ratio. Shahnawaz M; Sharoar MG; Shin SY; Park IS J Pept Sci; 2013 Sep; 19(9):545-53. PubMed ID: 23853087 [TBL] [Abstract][Full Text] [Related]
13. Reduction of Abeta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin. Haugabook SJ; Le T; Yager D; Zenk B; Healy BM; Eckman EA; Prada C; Younkin L; Murphy P; Pinnix I; Onstead L; Sambamurti K; Golde TE; Dickson D; Younkin SG; Eckman CB FASEB J; 2001 Jan; 15(1):16-18. PubMed ID: 11099491 [TBL] [Abstract][Full Text] [Related]
14. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits. Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908 [TBL] [Abstract][Full Text] [Related]
15. The turn formation at positions 22 and 23 in the 42-mer amyloid beta peptide: the emerging role in the pathogenesis of Alzheimer's disease. Murakami K; Masuda Y; Shirasawa T; Shimizu T; Irie K Geriatr Gerontol Int; 2010 Jul; 10 Suppl 1():S169-79. PubMed ID: 20590832 [TBL] [Abstract][Full Text] [Related]
16. The calcineurin inhibitor Sarah (Nebula) exacerbates Aβ42 phenotypes in a Drosophila model of Alzheimer's disease. Lee S; Bang SM; Hong YK; Lee JH; Jeong H; Park SH; Liu QF; Lee IS; Cho KS Dis Model Mech; 2016 Mar; 9(3):295-306. PubMed ID: 26659252 [TBL] [Abstract][Full Text] [Related]
17. Expressing miR-282 mitigates Aβ42-induced neurodegeneration in Alzheimer's model in Drosophila. Huang YH; Shih HW; Tsai YC Biochem Biophys Res Commun; 2024 Nov; 734():150768. PubMed ID: 39357339 [TBL] [Abstract][Full Text] [Related]
18. Linking aβ42-induced hyperexcitability to neurodegeneration, learning and motor deficits, and a shorter lifespan in an Alzheimer's model. Ping Y; Hahm ET; Waro G; Song Q; Vo-Ba DA; Licursi A; Bao H; Ganoe L; Finch K; Tsunoda S PLoS Genet; 2015 Mar; 11(3):e1005025. PubMed ID: 25774758 [TBL] [Abstract][Full Text] [Related]
19. Toxicity of Alzheimer's disease-associated Aβ peptide is ameliorated in a Drosophila model by tight control of zinc and copper availability. Hua H; Münter L; Harmeier A; Georgiev O; Multhaup G; Schaffner W Biol Chem; 2011 Oct; 392(10):919-26. PubMed ID: 21801085 [TBL] [Abstract][Full Text] [Related]
20. Aß40 displays amyloidogenic properties in the non-transgenic mouse brain but does not exacerbate Aß42 toxicity in Drosophila. De Mena L; Smith MA; Martin J; Dunton KL; Ceballos-Diaz C; Jansen-West KR; Cruz PE; Dillon KD; Rincon-Limas DE; Golde TE; Moore BD; Levites Y Alzheimers Res Ther; 2020 Oct; 12(1):132. PubMed ID: 33069251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]